This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Outcomes over 10 years suggest that image-guided thermal ablation is a safe and effective option for patients with papillary thyroid carcinoma, according to a study published November 7 in JAMA Otolaryngology-Head & Neck Surgery. The emerging procedure has a relatively short history, with long-term findings now supporting its use over more invasive surgery, noted lead author Lin Yan, MD, of the Chinese PLA General Hospital in Beijing.
Medical surveys are an easy way to make a few bucks at a good hourly rate (well, maybe at least for a resident), and there are multiple sites offering surveys to physicians. The caveat is that, of course, most survey sponsors are typically looking for board-certified physicians with multiple years of experience, particularly in sub-specialties. The less experience you have, the more you need to be prepared to get screened out of what seem like promising survey opportunities.
Connecticut-based company Hyperfine has secured CE marking under the European Medical Device Regulation for its Swoop portable brain MRI system. The company in 2023 secured initial CE certification for the Swoop system. Hyperfine said this latest approval will help position the company to launch the system broadly across Europe. Hyperfine in 2024 expanded its global distribution network with partnerships established in 13 European countries, including the five major European markets.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Spectral AI posted revenue increases for the third quarter of the 2024 fiscal year and is making plans to spin off its subsidiary company. The company reported that revenue (end-September 30) for the quarter rose 138%, from $3.4 million in the same period last year to $8.2 million this year. The increase reflects the company's work on its Spectral's Project BioShield (PBS) contract with the Biomedical Advanced Research and Development Authority (BARDA) and awards and work performed on other U.S.
Spectral AI posted revenue increases for the third quarter of the 2024 fiscal year and is making plans to spin off its subsidiary company. The company reported that revenue (end-September 30) for the quarter rose 138%, from $3.4 million in the same period last year to $8.2 million this year. The increase reflects the company's work on its Spectral's Project BioShield (PBS) contract with the Biomedical Advanced Research and Development Authority (BARDA) and awards and work performed on other U.S.
tim.hodson Thu, 11/07/2024 - 11:25 Nov. 1, 2024 — The Centers for Medicare & Medicaid Services (CMS) have announced a significant adjustment to the Hospital Outpatient Prospective Payment System (HOPPS). Under the new policy, CMS will unpackage and pay separately for diagnostic radiopharmaceuticals with per-day costs exceeding $630, removing financial barriers that have long hindered patient access to essential nuclear medicine diagnostic procedures.
Patients need healthcare designed and accessible to them, regardless of their objectives and needs. This has pushed the healthcare landscape to evolve, offering more opportunities for providers to meet their patients’ needs. Integrated care models effectively combine physical, virtual, and at-home care options for patients, enabling them to receive the care they need in a way that is not only accessible but also more desirable.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
With 118th U.S. Congress House and Senate members scheduled to return to work November 12, the American College of Radiology released a review of the top three pieces of legislation for year-end consideration and industry support: The Medicare Patient Access and Practice Stabilization (MPAPS) Act of 2024 (HR 10073) , and/or similar legislation in the Senate, would eliminate the Medicare Physician Fee Schedule (MPFS) conversion factor reduction and add an update equivalent to one half of the Medi
Radiation therapy clinic software provider RaySearch Laboratories posted increased net sales of 293.3 million Swedish krona ($27.1 million U.S.) for its third-quarter and net sales of 869.4 million Swedish krona ($80.2 million) for the nine months. For the period (end-September 30), the Stockholm, Sweden-based company posted a profit after tax of 45.4 million Swedish krona ($4.2 million), an increase of 110% over the same period last year.
tim.hodson Thu, 11/07/2024 - 10:44 Nov. 4, 2024 — Volpara Health has announced a new contract with the U.S. Defense Health Agency (DHA) valued at $7.3 million over five years. The contract will see Volpara's Patient Hub, an advanced mammography reporting, cancer risk assessment and patient tracking system, deployed across DHA's military health system.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
United Imaging has received Health Canada approval for multiple digital PET/CT models in its uMI Panorama product family. uMI Panorama features a National Electrical Manufacturer Association (NEMA) PET resolution of 2.9 mm, a time of flight (TOF) resolution of sub-200 ps, and a CT rotation of 0.25-second rotation speed for quantitative accuracy and small lesion detectability.
tim.hodson Thu, 11/07/2024 - 10:57 Oct 31, 2024 — Sirona Medical recently added added nine new radiology practices to its Unify platform. Among them are Kansas Imaging Consultants, Radiologic Associates of Fredericksburg, Diagnostic Medical Group of Southern California, Cascaid Health, Newport Diagnostic Center, and Jacobson Memorial Hospital. These practices join Sirona’s nationwide network, marking a significant milestone in the platform’s growth and solidifying its position as a leader in
Bayer has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Medrad Centargo CT Injection System. The system is a multipatient injector that integrates with Bayer’s portfolio of products, especially in high-volume CT suites. It is designed to minimize preparation time to under two minutes, streamlines data entry, and features a piston-based technology that allows for features such as dual flow to deliver contrast and saline at the same time, the company said.
Mechanical engineers have developed a system of artificial cilia capable of monitoring mucus conditions in human airways to better detect infection, airway obstruction, or the severity of diseases like Cystic Fibrosis (CF), Chronic Obstructive Pulmonary Diseases (COPD) and lung cancer.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Medical imaging and data management firm Mach7 Technologies has joined the Amazon Web Services (AWS) Partner Network (APN). The APN is a global community of AWS Partners that leverage programs, expertise, and resources to build, market, and sell customer offerings. Mach7 said that by joining the APN, it can leverage AWS services to access patient information across the healthcare enterprise.
Leo Sugrue, MD, PhD, develops non-invasive image-guided neuromodulation techniques to treat multiple psychiatric disorders. Watch him explain these options for patient treatment.
AI technology is advancing rapidly in radiology departments around the world, and few know its transformative potential better than Scott Williams, MD, Medical Director, Chief of Service and Vice Chairman, Department of Radiology at Hoag. In a recent discussion, Dr. Williams shared invaluable insights on how AI is reshaping radiology practice, enhancing patient care and ensuring efficiency.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
An AI algorithm can identify breast cancer in MRI scans up to one year earlier than when radiologists typically detect it, potentially improving early detection among high-risk women.
Martin Kamen worked tirelessly for three days, making the groundbreaking discovery of carbon-14 that changed science. The post Carbon-14 Unleashed: Martin Kamen’s Epic Quest that Changed Science Forever appeared first on Open MedScience.
To evaluate oncological outcomes, abscopal effect, and adverse events of pulsed electrical field (PEF) ablation of tumors in the chest, abdomen, and pelvis.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
264 
Let's personalize your content